Andreas Wicki - Founder & CEO @ HBM Partners

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Andreas Wicki is the Founder & CEO of HBM Partners.He attend to the University of Bern in 1980.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	1mg	HBM Healthcare Investments	—	Debt Financing - 1mg	obfuscated obfuscation
obfuscated obfuscation	1mg	HBM Healthcare Investments	—	Series D - 1mg	obfuscated obfuscation
obfuscated obfuscation	Y-mAbs Therapeutics	HBM Healthcare Investments	—	Private Equity Round - Y-mAbs Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Y-mAbs Therapeutics	HBM Healthcare Investments	Yes	Private Equity Round - Y-mAbs Therapeutics	obfuscated obfuscation
obfuscated obfuscation	BaseHealth	HBM Healthcare Investments	Yes	Series C - BaseHealth	obfuscated obfuscation
obfuscated obfuscation	1mg	HBM Healthcare Investments	Yes	Series C - 1mg	obfuscated obfuscation
obfuscated obfuscation	1mg	HBM Healthcare Investments	Yes	Venture Round - 1mg	obfuscated obfuscation
obfuscated obfuscation	1mg	HBM Healthcare Investments	Yes	Series B - 1mg	obfuscated obfuscation

Number of Current Jobs

Number of Past Jobs

has

current jobs as

Founder & CEO

and

CEO

. Additionally,

has had

past job as the

SVP

Organization Name	Title At Company	Start Date	End Date
MDS Pharma Services	SVP	1990	2001

Number of Current Board & Advisor Roles

is the

Board Member

Hub Name	CB Rank (Hub)
Private Equity Firms with Investments in Switzerland	47,983
Switzerland Venture Capital Investors	31,169
Switzerland Early Stage Venture Investors	24,752
Europe, Middle East, and Africa (EMEA) Investors with Funds Raised in 2012	28,741
Late Stage Venture Investors with Investments in Zurich	33,988
Early Stage Venture Investors with Investments in Switzerland	13,675
Europe Investors with Funds Raised in 2012	42,821
Private Equity Firms with Investments in Zurich	77,677
Early Stage Venture Investors with Investments in Zurich	25,631
Switzerland Late Stage Venture Investors	57,353

studied at

There is no recent news or activity for this profile.